Publications | Lund University Publications

1 – 10 of 20

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+med-lni+or+(documenttype+any+%22bookEditor+conferenceEditor%22+and+editor+exact+med-lni)&q=department+exact+v1000561&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2017
Mark Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients : a prospective observational study
Benediktsson, Sigurdur ^LU ; Lazarevic, Vladimir ^LU ; Nilsson, Lars ^LU ; Kjeldsen-Kragh, Jens ^LU ; Schött, Ulf ^LU and Kander, Thomas ^LU (2017) In European Journal of Haematology p.559-568
- Contribution to journal › Article
2014
Mark Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations.
Santini, Valeria ; Prebet, Thomas ; Fenaux, Pierre ; Gattermann, Norbert ; Nilsson, Lars ^LU ; Pfeilstöcker, Michael ; Vyas, Paresh and List, Alan F (2014) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 38(12). p.1381-1391
- Contribution to journal › Scientific review
Mark Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study
Giagounidis, Aristoteles ; Mufti, Ghulam J. ; Mittelman, Moshe ; Sanz, Guillermo ; Platzbecker, Uwe ; Muus, Petra ; Selleslag, Dominik ; Beyne-Rauzy, Odile ; te Boekhorst, Peter and del Canizo, Consuelo , et al. (2014) In European Journal of Haematology 93(5). p.429-438
- Contribution to journal › Article
Mark Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo.
Woll, Petter S ; Kjällquist, Una ; Chowdhury, Onima ; Doolittle, Helen ; Wedge, David C ; Thongjuea, Supat ; Erlandsson, Rikard ; Ngara, Mtakai ; Anderson, Kristina ^LU and Deng, Qiaolin , et al. (2014) In Cancer Cell 25(6). p.794-808
- Contribution to journal › Article
2011
Mark A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
Fenaux, Pierre ; Giagounidis, Aristoteles ; Selleslag, Dominik ; Beyne-Rauzy, Odile ; Mufti, Ghulam ; Mittelman, Moshe ; Muus, Petra ; Boekhorst, Peter Te ; Sanz, Guillermo and del Canizo, Consuelo , et al. (2011) In Blood 118(14). p.3765-3776
- Contribution to journal › Article
2010
Mark Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
Grovdal, Michael ; Karimi, Mohsen ; Khan, Rasheed ; Aggerholm, Anni ; Antunovic, Petar ; Astermark, Jan ^LU ; Bernell, Per ; Engstrom, Lena-Maria ; Kjeldsen, Lars and Linder, Olle , et al. (2010) In British Journal of Haematology 150(3). p.293-302
- Contribution to journal › Article
Mark Persistent malignant stem cells in del(5q) myelodysplasia in remission.
Tehranchi, Ramin ; Woll, Petter S ; Anderson, Kristina ; Buza-Vidas, Natalija ; Mizukami, Takuo ; Mead, Adam J ; Åstrand-Grundström, Ingbritt ^LU ; Strömbeck, Bodil ; Biloglav, Andrea ^LU and Ferry, Helen , et al. (2010) In New England Journal of Medicine 363(11). p.1025-1037
- Contribution to journal › Article
2009
Mark Expression of P53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5Q)
Jadersten, M. S. ; Saft, L. ; Garelius, H. ; Hast, R. ; Nilsson, Lars ^LU ; Samuelsson, J. ; Porwit, A. and Hellstrom-Lindberg, E. (2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0257-0257
- Contribution to journal › Published meeting abstract
Mark Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities
Mollgard, Lars ; Nilsson, Lars ^LU ; Kjeldsen, Lars ; Dybedal, Ingunn ; Dufva, Inge Hogh ; Garelius, Hege ; Norgaard, Jan Maxwell ; Linder, Olle ; Ejerblad, Elisabeth and Astermark, Jan , et al. (2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.52-52
- Contribution to journal › Published meeting abstract
Mark Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)
Jadersten, M. ; Saft, L. ; Garelius, H. ; Hast, R. ; Nilsson, Lars ^LU ; Samuelsson, J. ; Porwit, A. and Hellstrom-Lindberg, E. (2009) 10th International Symposium on Myelodysplastic Syndromes In Leukemia Research 33. p.39-39
- Contribution to journal › Published meeting abstract

« previous
1
2
next »

your query:: Remove author: Nilsson, Lars (LU); Remove department: Stem Cell Center